ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±Àî¾§¡¢¡¢ÌÆÑÞÀö£©×÷Ϊ×î³£¼ûµÄÑÛ²¡Ö®Ò»£¬£¬¸ÉÑÛÖ÷ÒªÌåÏÖΪÑ۸ɡ¢¡¢ÑÛɬ¡¢¡¢ÒìÎï¸ÐµÈ£¬£¬ÑÏÖØÓ°Ï컼ÕßµÄÉúÑÄÖÊÁ¿¡£¡£½üÄêÀ´£¬£¬¸ÉÑÛ·¢²¡ÂÊÖðÄêÉÏÉý£¬£¬ÒÑÈ»³ÉΪȫÇòÐÔ¿µ½¡ÎÊÌâ¡£¡£ÏÖÔÚ£¬£¬¸ÉÑÛÖÎÁƵÄÒ»ÏßÓÃҩΪÈ˹¤ÀáÒº£¬£¬È»¶ø£¬£¬ºã¾ÃʹÓÃÈ˹¤Àá񼮮·Ñ¸ß£¬£¬Í¬Ê±£¬£¬´ó×ÚµÄÑÛҩˮƿÒà»á¶ÔÇéÐÎÔì³É¼ç¸º¡£¡£
¸ÉÑ۵ı¬·¢ÓëÉúÑÄ·½Ê½Ï¢Ï¢Ïà¹Ø£¬£¬ÒÖÓô¡¢¡¢½¹ÂǵÈÐÄÀí״̬Óë¸ÉÑ۵ĿªÕ¹ÒàÓÐϸÃÜÁªÏµ¡£¡£Ë×»°Ëµ¡°Ð¦ÊÇÁ¼Ò©¡±£¬£¬´ó×ÚÖ¤¾ÝÅú×¢£¬£¬¡°Ð¦µÄÁÆ·¨¡±¿ÉÒÔ»º½âÒÖÓô¡¢¡¢½¹ÂÇ¡¢¡¢Ñ¹Á¦ºÍÂýÐÔÌÛÍ´£¬£¬²¢ÔÚÒÑÍùÎåÊ®ÄêÒѱ»Ö¤Êµ¿ÉÓÐÓø¨ÖúÖÎÁÆÐÄÀí¼²²¡¡¢¡¢ÌÇÄò²¡¡¢¡¢Æ«Í·Í´µÈһϵÁÐÂýÐÔ²¡¡£¡£ÄÇô£¬£¬¡°Ð¦µÄÁÆ·¨¡±¶Ô¸ÉÑÛÕâÖÖÓëÇéÐ÷Ïà¹ØµÄÂý²¡ÊÇ·ñÓÐÓÃÄØ£¿£¿£¿ÈôÓÐÓ㬣¬Óë×î³£ÓõÄÈ˹¤ÀáÒº£¨0.1%²£Á§ËáÄÆµÎÑÛÒº£©µÄÁÆÐ§ÓÖÓкβî±ðÄØ£¿£¿£¿
¿ËÈÕ£¬£¬ngµç×ÓÓÎÏ·ÖÐɽÑÛ¿ÆÖÐÐÄÁºÁèÒã¡¢¡¢ÁõÞÈÖ¾½ÌÊÚÍŶӺÍÏÃÃÅ´óѧÑÛ¿ÆÑо¿ËùÁõ׿¹ú½ÌÊÚÍŶÓÔÚ¹ú¼Ê¶¥¼¶Ò½Ñ§ÆÚ¿¯The BMJ £¨¡¶Ó¢¹úҽѧÔÓÖ¾¡·£¬£¬ÖпÆÔºÒ»ÇøTop£©½ÒÏþÌâΪ¡°Effect of laughter exercise versus 0.1% sodium hyaluronic acid on ocular surface discomfort in dry eye disease: non-inferiority randomised controlled trial¡±£¨¡°Ð¦µÄѵÁ·¡±vs.0.1%²£Á§ËáÄÆ¶Ô¸ÉÑÛµÄÓ°Ïì:Ò»Ïî·ÇÁÓÐ§Ëæ»ú±ÈÕÕʵÑ飩µÄÑо¿ÂÛÎÄ£¬£¬Ö¤ÊµÁË¡°Ð¦µÄѵÁ·¡±¶Ô¸ÉÑÛµÄÖÎÁÆÐ§¹û¡£¡£±¾ÂÛÎÄÊÇngµç×ÓÓÎÏ·ÖÐɽÑÛ¿ÆÖÐÐÄÔÚThe BMJ£¨¡¶Ó¢¹úҽѧÔÓÖ¾¡·£©ÉϵÄÊׯªÒÔ×îºóͨѶ×÷Õߺ͵ÚÒ»×÷Õßµ¥Î»½ÒÏþµÄÔ´´ÁÙ´²Ñо¿ÂÛÎÄ£¬£¬Ò²ÊÇÎÒ¹úÑÛ¿ÆÁìÓòÉÙÉÙÊýÔÚ¹ú¼ÊÁÙ´²ËÄ´óҽѧÆÚ¿¯½ÒÏþµÄÁÙ´²Ñо¿ÂÛÖø¡£¡£
Ñо¿ÍŶÓͨ¹ýÒ»ÏîǰհÐÔ¡¢¡¢·ÇÁÓÐ§Ëæ»ú±ÈÕÕÁÙ´²Ñо¿£¬£¬ÄÉÈë299Ãû²»°éÖÐÖØ¶È½ÇĤӫ¹âËØÈ¾É«µÄÓÐÖ¢×´¸ÉÑÛ»¼Õߣ¬£¬Ëæ»ú·ÖΪ2×飬£¬»®·Ö½ÓÊÜ8ÖÜÈ˹¤ÀáÒº£¨0.1%²£Á§ËáÄÆ£©ÖÎÁÆ£¬£¬»ò¡°Ð¦µÄѵÁ·¡±£¬£¬½ÓÄÉС³ÌÐò¼Í¼¸ÉÔ¤ÇéÐΡ£¡£Ñо¿ÍŶӯ¾Ö¤Ã沿¼°ÑÛ²¿¼¡ÈâÔ˶¯Éè¼Æ³ö¡°Ð¦µÄѵÁ·¡±¿ÚÁ£º£º¡°hihihi£¨Æ´ÒôÆ´¶Á£©£¬£¬¹þ¹þ¹þ£¬£¬ÇÑ×ÓÇÑ×ÓÇÑ×Ó£¬£¬ÆßϲÆßϲÆßϲ£¬£¬¹þ¹þ¹þ¹þ¹þ¹þ¡±£¬£¬30±é¿ÚÁîΪ1´ÎѵÁ·£¬£¬Ò»Ìì¾ÙÐÐѵÁ·4´Î¡£¡£ÔÚ¸ÉÔ¤8Öܺ󣬣¬¡°Ð¦µÄѵÁ·¡±×éºÍ0.1%²£Á§ËáÄÆ×黼ÕßµÄÖ¢×´¼°ÌåÕ÷¾ùÓÐËù¸ÄÉÆ£¬£¬ÇÒÔÚÖ÷Ҫϳ¡Ö¸±êÑÛ±í¼²²¡Ö¸ÊýÆÀ·Ö£¨Ò»ÖÖȨºâ¸ÉÑÛÖ÷¹ÛÑÏÖØ³Ì¶ÈµÄÖ¸±ê£©ÖУ¬£¬¡°Ð¦µÄѵÁ·¡±×é²»ÑÇÓÚ0.1%²£Á§ËáÄÆ£¬£¬ÉõÖÁÔÚһЩÌåÕ÷¸ÄÉÆÖУ¬£¬¡°Ð¦µÄѵÁ·¡±ÓÅÓÚ0.1%²£Á§ËáÄÆ¡£¡£±¾Ñо¿Ö¤ÊµÁË¡°Ð¦µÄѵÁ·¡±ÔÚ¸ÉÑÛ»¼ÕßµÄÖÎÁÆÐ§¹û£¬£¬´ÓոнǶÈÌá³öÁËÒ»ÖÖÓÐÓᢡ¢Çå¾²¡¢¡¢µÍ±¾Ç®ÇÒÇéÐÎÓѺõķÇÒ©ÎïÖÎÁÆÊֶΡ£¡£

¡°Ð¦µÄѵÁ·¡±²Ù×÷Ö¸ÒýºÍ´ò¿¨Ð¡³ÌÐò
±¾Ñо¿Õ¹ÏÖÁË¡°Ð¦µÄѵÁ·¡±ÓëÈ˹¤ÀáÒº£¨0.1%²£Á§ËáÄÆ£©ÁÆÐ§Ï൱£¬£¬ÇÒÔÚÑÛ²¿ÌåÕ÷¸ÄÉÆÉÏÓÅÓÚÈ˹¤ÀáÒº£¨0.1%²£Á§ËáÄÆ£©£¬£¬ÕâÒ»Ñо¿Ð§¹ûΪ¸ÉÑÛµÄÖÎÁÆÌṩÁËոеÄÕ½ÂÔ£¬£¬Îªºã¾ÃÒÀÀµÑÛÒ©Ë®µÄ¸ÉÑÛ»¼Õß´øÀ´ÐÂÏ£Íû£¬£¬Í¬Ê±Ò²Îª¸ÉÑÛ·¢²¡»úÖÆµÄÉîÈëÑо¿ÌṩÁËеÄ˼Ð÷¡£¡£

¡°Ð¦µÄѵÁ·¡±¶Ô¸ÉÑÛÖ¢×´µÄ¸ÄÉÆÐ§¹û²»ÑÇÓÚ0.1%²£Á§ËáÄÆ
±¾Ñо¿ngµç×ÓÓÎÏ·ÖÐɽÑÛ¿ÆÖÐÐÄ¡¢¡¢ÑÛ²¡·ÀÖÎÌìÏÂÖØµãʵÑéÊÒΪµÚÒ»×÷Õßµ¥Î»ºÍ×îºóͨѶ×÷Õßµ¥Î»¡£¡£ÖÐɽÑÛ¿ÆÖÐÐÄÖ÷ÖÎҽʦÀî¾§¡¢¡¢²©Ê¿Ñо¿ÉúÁÎÓ±ÁÕºÍ˶ʿÑо¿ÉúÕÅÊ«ÑþΪÅäºÏµÚÒ»×÷Õߣ¬£¬ÖÐɽÑÛ¿ÆÖÐÐÄÁºÁèÒã½ÌÊÚ¡¢¡¢ÁõÞÈÖ¾½ÌÊÚºÍÏÃÃÅ´óѧÑÛ¿ÆÑо¿ËùÁõ׿¹ú½ÌÊÚΪÅäºÏͨѶ×÷Õß¡£¡£
ÂÛÎÄÁ´½Ó£º£º£º
https://www.bmj.com/content/386/bmj-2024-080474